Development of the Dutch translational knowledge agenda for inherited metabolic diseases
Abstract Background Inherited metabolic diseases (IMDs) may have considerable implications for patients and their families. Despite their individual rarity, covering a spectrum of over 1800 distinct diseases, the diseases collectively exert a significant impact, with often lifelong disabilities. The...
Saved in:
| Main Authors: | , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-01-01
|
| Series: | JIMD Reports |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/jmd2.12455 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832583756152569856 |
|---|---|
| author | I. J. Hieltjes J. H. van derLee M. C. Groenendijk G. vanHaaften P. M. vanHasselt R. J. Lunsing G. J. J. vanProoijen E. M. deRuiter F. J. vanSpronsen N. M. Verhoeven‐Duif A. deVreugd M. Wagenmakers H. Zweers H. Dekker H. R. Waterham C. D. vanKarnebeek R. J. A. Wanders R. A. Wevers |
| author_facet | I. J. Hieltjes J. H. van derLee M. C. Groenendijk G. vanHaaften P. M. vanHasselt R. J. Lunsing G. J. J. vanProoijen E. M. deRuiter F. J. vanSpronsen N. M. Verhoeven‐Duif A. deVreugd M. Wagenmakers H. Zweers H. Dekker H. R. Waterham C. D. vanKarnebeek R. J. A. Wanders R. A. Wevers |
| author_sort | I. J. Hieltjes |
| collection | DOAJ |
| description | Abstract Background Inherited metabolic diseases (IMDs) may have considerable implications for patients and their families. Despite their individual rarity, covering a spectrum of over 1800 distinct diseases, the diseases collectively exert a significant impact, with often lifelong disabilities. The United for Metabolic Diseases consortium was established to catalyze research with translation into the best possible care. Aim To generate a translational knowledge agenda, which identifies and prioritizes research questions, directly relevant to patient care or for IMD patients and their families. Methods and Results Following a process established by the Knowledge Institute of the Dutch Association of Medical Specialists, we generated a comprehensive translational knowledge agenda for IMDs. A multidisciplinary steering committee, composed of 12 diverse metabolic experts collected research questions through an online questionnaire using snowballing. The 462 proposed questions were categorized and prioritized during a meeting attended by 22 representatives of all stakeholder groups. The resulting top 10 research questions cover multiple themes, i.e. prediction of disease progression, development of novel tools, mechanistic insights, improved diagnostics, therapeutic integration of multi‐omics techniques, assessment of impact on daily life, expanding treatment avenues, optimal study designs, effect of lifestyle interventions, and data utilization using FAIR principles. Discussion This collective endeavor reflects the collaborative spirit needed for rare disease research. This knowledge agenda will guide funding directions and applications but will also boost interdisciplinary collaboration to push the field of IMDs research forward in a renewed UMD consortium. Patient engagement, transparency, and a comprehensive approach make this knowledge agenda a pivotal step toward addressing the pressing research needs and priorities in this domain. |
| format | Article |
| id | doaj-art-f53a2e3a66144d5eba79ac4bd117235e |
| institution | Kabale University |
| issn | 2192-8312 |
| language | English |
| publishDate | 2025-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | JIMD Reports |
| spelling | doaj-art-f53a2e3a66144d5eba79ac4bd117235e2025-01-28T07:38:32ZengWileyJIMD Reports2192-83122025-01-01661n/an/a10.1002/jmd2.12455Development of the Dutch translational knowledge agenda for inherited metabolic diseasesI. J. Hieltjes0J. H. van derLee1M. C. Groenendijk2G. vanHaaften3P. M. vanHasselt4R. J. Lunsing5G. J. J. vanProoijen6E. M. deRuiter7F. J. vanSpronsen8N. M. Verhoeven‐Duif9A. deVreugd10M. Wagenmakers11H. Zweers12H. Dekker13H. R. Waterham14C. D. vanKarnebeek15R. J. A. Wanders16R. A. Wevers17Knowledge Institute of the Dutch Association of Medical Specialists Utrecht The NetherlandsKnowledge Institute of the Dutch Association of Medical Specialists Utrecht The NetherlandsMetaPACT The NetherlandsUnited for Metabolic Diseases (UMD) The NetherlandsUnited for Metabolic Diseases (UMD) The NetherlandsUnited for Metabolic Diseases (UMD) The NetherlandsMetaPACT The NetherlandsUnited for Metabolic Diseases (UMD) The NetherlandsUnited for Metabolic Diseases (UMD) The NetherlandsUnited for Metabolic Diseases (UMD) The NetherlandsUnited for Metabolic Diseases (UMD) The NetherlandsUnited for Metabolic Diseases (UMD) The NetherlandsUnited for Metabolic Diseases (UMD) The NetherlandsMetaPACT The NetherlandsUnited for Metabolic Diseases (UMD) The NetherlandsDepartment of Pediatrics and Human Genetics, Emma Center for Personalized Medicine Amsterdam UMC Amsterdam The NetherlandsUnited for Metabolic Diseases (UMD) The NetherlandsUnited for Metabolic Diseases (UMD) The NetherlandsAbstract Background Inherited metabolic diseases (IMDs) may have considerable implications for patients and their families. Despite their individual rarity, covering a spectrum of over 1800 distinct diseases, the diseases collectively exert a significant impact, with often lifelong disabilities. The United for Metabolic Diseases consortium was established to catalyze research with translation into the best possible care. Aim To generate a translational knowledge agenda, which identifies and prioritizes research questions, directly relevant to patient care or for IMD patients and their families. Methods and Results Following a process established by the Knowledge Institute of the Dutch Association of Medical Specialists, we generated a comprehensive translational knowledge agenda for IMDs. A multidisciplinary steering committee, composed of 12 diverse metabolic experts collected research questions through an online questionnaire using snowballing. The 462 proposed questions were categorized and prioritized during a meeting attended by 22 representatives of all stakeholder groups. The resulting top 10 research questions cover multiple themes, i.e. prediction of disease progression, development of novel tools, mechanistic insights, improved diagnostics, therapeutic integration of multi‐omics techniques, assessment of impact on daily life, expanding treatment avenues, optimal study designs, effect of lifestyle interventions, and data utilization using FAIR principles. Discussion This collective endeavor reflects the collaborative spirit needed for rare disease research. This knowledge agenda will guide funding directions and applications but will also boost interdisciplinary collaboration to push the field of IMDs research forward in a renewed UMD consortium. Patient engagement, transparency, and a comprehensive approach make this knowledge agenda a pivotal step toward addressing the pressing research needs and priorities in this domain.https://doi.org/10.1002/jmd2.12455gene therapyknowledge agendametabolomicsnatural coursepathophysiologypatient and public involvement |
| spellingShingle | I. J. Hieltjes J. H. van derLee M. C. Groenendijk G. vanHaaften P. M. vanHasselt R. J. Lunsing G. J. J. vanProoijen E. M. deRuiter F. J. vanSpronsen N. M. Verhoeven‐Duif A. deVreugd M. Wagenmakers H. Zweers H. Dekker H. R. Waterham C. D. vanKarnebeek R. J. A. Wanders R. A. Wevers Development of the Dutch translational knowledge agenda for inherited metabolic diseases JIMD Reports gene therapy knowledge agenda metabolomics natural course pathophysiology patient and public involvement |
| title | Development of the Dutch translational knowledge agenda for inherited metabolic diseases |
| title_full | Development of the Dutch translational knowledge agenda for inherited metabolic diseases |
| title_fullStr | Development of the Dutch translational knowledge agenda for inherited metabolic diseases |
| title_full_unstemmed | Development of the Dutch translational knowledge agenda for inherited metabolic diseases |
| title_short | Development of the Dutch translational knowledge agenda for inherited metabolic diseases |
| title_sort | development of the dutch translational knowledge agenda for inherited metabolic diseases |
| topic | gene therapy knowledge agenda metabolomics natural course pathophysiology patient and public involvement |
| url | https://doi.org/10.1002/jmd2.12455 |
| work_keys_str_mv | AT ijhieltjes developmentofthedutchtranslationalknowledgeagendaforinheritedmetabolicdiseases AT jhvanderlee developmentofthedutchtranslationalknowledgeagendaforinheritedmetabolicdiseases AT mcgroenendijk developmentofthedutchtranslationalknowledgeagendaforinheritedmetabolicdiseases AT gvanhaaften developmentofthedutchtranslationalknowledgeagendaforinheritedmetabolicdiseases AT pmvanhasselt developmentofthedutchtranslationalknowledgeagendaforinheritedmetabolicdiseases AT rjlunsing developmentofthedutchtranslationalknowledgeagendaforinheritedmetabolicdiseases AT gjjvanprooijen developmentofthedutchtranslationalknowledgeagendaforinheritedmetabolicdiseases AT emderuiter developmentofthedutchtranslationalknowledgeagendaforinheritedmetabolicdiseases AT fjvanspronsen developmentofthedutchtranslationalknowledgeagendaforinheritedmetabolicdiseases AT nmverhoevenduif developmentofthedutchtranslationalknowledgeagendaforinheritedmetabolicdiseases AT adevreugd developmentofthedutchtranslationalknowledgeagendaforinheritedmetabolicdiseases AT mwagenmakers developmentofthedutchtranslationalknowledgeagendaforinheritedmetabolicdiseases AT hzweers developmentofthedutchtranslationalknowledgeagendaforinheritedmetabolicdiseases AT hdekker developmentofthedutchtranslationalknowledgeagendaforinheritedmetabolicdiseases AT hrwaterham developmentofthedutchtranslationalknowledgeagendaforinheritedmetabolicdiseases AT cdvankarnebeek developmentofthedutchtranslationalknowledgeagendaforinheritedmetabolicdiseases AT rjawanders developmentofthedutchtranslationalknowledgeagendaforinheritedmetabolicdiseases AT rawevers developmentofthedutchtranslationalknowledgeagendaforinheritedmetabolicdiseases |